Physician

Michael S Lee, M.D.

According to 2025 Medicare claims, Michael Lee, M.D. (NPI: 1417969395) practices interventional pain management (ipm) in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Chester, PA. This provider's primary affiliated billing organization is PREMIER ORTHOPAEDIC AND SPORTS MEDICINE ASSOCIATES, LTD (NPI: 1215987243; TIN: 232866529) and primary practice location at 19341-2567.

Lee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 553 traditional Medicare patients, billed 3,273 HCPCS/CPT codes, and received $216,620 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 526 prescription claims across 214 beneficiaries totaling $4,837 in drug costs, led by Celecoxib (Celecoxib). 2018 DME data shows 12 claims. Open Payments data shows 1 records totaling $30. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $14,236 to $4,837. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,019 to $974.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	451	5,141	$294,174
2016	491	5,012	$278,082
2017	489	3,165	$200,351
2018	445	3,142	$217,366
2019	459	3,137	$237,694
2020	402	2,372	$173,888
2021	468	2,785	$224,670
2022	542	2,945	$220,615
2023	529	2,801	$211,226
2024	553	3,273	$216,620

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	144	440	$14,236
2016	157	464	$11,633
2017	112	262	$6,090
2018	106	252	$5,617
2019	101	240	$5,303
2020	102	301	$4,063
2021	125	325	$3,716
2022	162	388	$6,242
2023	153	346	$2,854
2024	214	526	$4,837

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	23	$905
2017	N/R	20	$574
2018	N/R	12	$441
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	214	279	$102
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	166	166	$80
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	103	151	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	405	1,103	$68
64484	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level	123	155	$40

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Celecoxib	Celecoxib	153	4,770	$3,099
Methylprednisolone	Methylprednisolone	83	498	$447
Gabapentin	Gabapentin	84	1,822	$436
Meloxicam	Meloxicam	65	1,950	$142
Tramadol Hcl	Tramadol Hcl	59	564	$131

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$30	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael S. Lee, M.D.?

Tedicare shows public-source Medicare data for Michael S. Lee, M.D. (NPI 1417969395), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael S. Lee, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael S. Lee, M.D.?

Michael S. Lee, M.D. is linked to PREMIER ORTHOPAEDIC AND SPORTS MEDICINE ASSOCIATES, LTD (billing NPI 1215987243) in the available physician profile data.

Does Michael S. Lee, M.D. have Open Payments data?

Michael S. Lee, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.